INTRODUCTION: @entity73 has long been recognized as a co-morbidity or sequel to @entity302 . This study was conducted to evaluate the degree and selectivity of involvement of memory, language and executive functions performance among @entity1 with temporal (TLE) versus @entity302 ( @entity302 ). METHODS: We prospectively enrolled adolescent and adult @entity1 with medically refractory focal @entity302 , who had undergone pre-surgical evaluation. Language, memory and executive function assessment was done using Western Aphasia Battery, PGI memory scale and battery of four executive function tests (trail making test A _ B, digit symbol test, Stroop Task and verbal fluency test), respectively. RESULTS: Among102 @entity1 enrolled (TLE-59, @entity302 -43), mean age of @entity1 23.04  8.3 years, 83 (82%) had impairment of more than one cognitive domain and 21 (21%) had all three domains involved. Severely impaired memory scores were found in 8.6% @entity1 with MTLE-HS, 8% of the rest of the @entity1 with TLE and 7% @entity1 with @entity302 . The differences in the mean scores were also not found statistically significant (p=0.669). Naming impairment was the most common language abnormality, although all @entity2026 subscores were similar for the @entity302 and TLE groups. Executive function impairment was the most common cognitive domain affected. Overall performance on executive function tests was found impaired in almost all @entity1 of both groups without any significant inter-group difference, except on Trail-A test, which revealed better results in @entity1 with mTLE-HS as compared to all other sub-groups. CONCLUSION: Our study shows that @entity2414 , language and executive function is common among @entity1 with drug @entity302 . The most @entity73 is in executive function. There is no significant difference in the degree, prevalence or selectivity of impairment in either of the three domains, between the TLE versus @entity302 groups.

Memory, executive function and language function are similarly impaired in both temporal and extra temporal XXXX -A prospective study.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity73 :: ('MESH:D003072', 'Disease') :: ['prevalent impairment', 'Cognitive impairment'] @entity2026 :: ('MESH:D001037', 'Disease') :: ['aphasia'] @entity302 :: ('MESH:D004827', 'Disease') :: ['ETLE', 'refractory epilepsy', 'extratemporal epilepsy', 'epilepsy'] @entity2414 :: ('MESH:D008569', 'Disease') :: ['impairment of memory']
@entity302 :: (MESH:D004827,Disease) :: ['refractory epilepsy']
